Efficacy and Safety of Fosmidomycin–Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon

by Ghyslain Mombo-Ngoma, Jonathan Remppis, Moritz Sievers et al.
Clinical Infectious Diseases, Published: 26 December 2017

8 pp. 521 kB

Artemisinin-based combination therapy (ACT) has made a major contribution to reducing the global malaria burden, but its role as first-line treatment is being eroded by the development of resistance. A priority is the development of new therapies with novel modes of action. Such therapies are being referred to as nonartemisinin-based combination therapies (NACTs). This is the first report of the use of the combination fosmidomycin–piperaquine. The combination appeared to have high efficacy and be safe and well tolerated despite observed transient changes in electrocardiogram with prolongation of the QT interval.

(Visited 9 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.